Transmission dynamics of SARS-CoV-2 Omicron variant infections in Hangzhou, Zhejiang, China, January-February 2022.

Authors:
Xin H; Wang Z; Feng S; Sun Z; Yu L and 3 more

Journal:
Int J Infect Dis

Publication Year: 2022

DOI:
10.1016/j.ijid.2022.10.033

PMCID:
PMC9616478

PMID:
36511336

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Int J Infect Dis

Abbreviation: Int J Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
An ancient coronavirus from individuals in France, circa 16th century.
Oumarou Hama H; Chenal T; Pible O and 3 more (2023) - Transparency Score: 4/6
Assessing the utility of pregnant women as a sentinel surveillance population for malaria in Geita,…
Munsey A; Kinyina A; Assenga M and 12 more (2023) - Transparency Score: 3/6
Association between nasopharyngeal colonization with multiple pneumococcal serotypes and total pneu…
Howard LM; Huang X; Chen W and 13 more (2023) - Transparency Score: 3/6
Autoantibodies against type I interferons in COVID-19 infection: A systematic review and meta-analy…
Wang X; Tang Q; Li H and 4 more (2023) - Transparency Score: 5/6
Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection.
Najafi-Fard S; Aiello A; Navarra A and 10 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest BJC consults for AstraZeneca, Fosun Pharma, GSK, Moderna, Pfizer, Roche, and Sanofi Pasteur. The others authors have no competing interests to declare."

Evidence found in paper:

"Funding This project was supported by a commissioned grant under the Health and Medical Research Fund from the Food and Health Bureau of the Hong Kong Special Administrative Region Government (grant no. CID-HKU2), AIR@InnoHK administered by Innovation and Technology Commission, and the Health Technology Programme (project no. A20220843) of the Hangzhou Health Commission. BJC is supported by a RGC Senior Research Fellow Scheme grant (HKU SRFS2021-7S03) from the Research Grants Council of the Hong Kong Special Administrative Region, China."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025